Click here for an update from The Motley Fool Co-Founders Tom and David Gardner.

ImmunoGen

IMGN

IMGN
ImmunoGen Stock Quote
$3.39 -$0.09 -2.6%
Price as of April 7, 2020, 4:30 p.m. EDT View Interactive IMGN Charts

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs.

Interactive Chart


News & Analysis: ImmunoGen

The Fool has written over 200 articles on ImmunoGen.

All

Market Moves

Earnings